TORONTO — Ireland is now permitting entry to travellers who’ve received mixed doses of COVID-19 vaccines.
According to the Irish Government, passengers are considered fully vaccinated if they have received any combination of a vaccine approved for use in Ireland. For example, if a passenger’s first dose was AstraZeneca and second dose was Pfizer, they are fully vaccinated seven days after the Pfizer dose.
Vaccines approved for use in Ireland include those approved by the European Medicines Agency (EMA) and some from the WHO Emergency Use Listing (EUL):
- Spikevax (previously Moderna) plus 14 days
- Vaxzevria (previously AstraZeneca)/Covishield plus 15 days
- Comirnaty (previously Pfizer-BioNTech) plus 7 days
- Janssen plus 14 days
- (Vero Cell) Inactivated/CoronaVac plus 14 days
- Inactivated COVID-19 (VERO CELL)/Sinopharm / BIBP plus 14 days
Passengers are not considered fully vaccinated until the below period has passed, based on their second vaccine:
- 15 days after the second AstraZeneca dose or second Covishield dose
- 7 days after the second Pfizer-BioNtech dose
- 14 days after the second Moderna dose
- 14 days after the single Janssen dose
- 14 days after the second Sinopharm dose (also called Vero Cell Inactivated)
All passengers travelling to Ireland must also fill out a Passenger Locator Form before departure and have valid proof of vaccination or recovery, or present evidence of a negative RT-PCR result from a test taken within 72 hours prior to arrival.
For more information about Ireland’s entry requirements click here.